Biotech

Digital

AI's promise, biotech's peril: How unequal access to computi...

Many biotechs remain locked out of the AI revolution by a combination of cost, complexity, and lack of access to state-of-the-art infrastructure.

News

UK biotech sees "strong finish" to 2025 financing

2025 was a challenging year for the UK biotech sector, but it ended the year with signs of "renewed confidence," says the BIA industry body.

News

Back of man wearing branded BioInnovation Institute top.

Novo Nordisk Foundation pledges €736m for European biotech

Novo Nordisk Foundation is pumping funding into a Copenhagen-based biotech incubator, seeking to address the challenge of funding access in Europe.

News

Insilico ends 2025 with $293m Hong Kong IPO

One of the pioneers in AI-powered drug discovery, Insilico Medicine, has completed an oversubscribed IPO in Hong Kong, raising around $293m.

Digital

Cracking the code: How European biotechs can win in the US m...

At Frontiers Health 2025, Mike Ryan, General Manager Europe at EVERSANA, tackled one of the most pressing questions for emerging pharma and biotech...

R&D

Future glances: More change, more tech, more harmonisation

According to Deloitte’s 2026 Life Sciences Outlook Survey, the life sciences sector might be becoming increasingly borderless, but only 41% of responding biopharma and medtech executives fe

AI's promise, biotech's peril: How unequal access to computi...

UK biotech sees "strong finish" to 2025 financing

Novo Nordisk Foundation pledges €736m for European biotech

Insilico ends 2025 with $293m Hong Kong IPO

Cracking the code: How European biotechs can win in the US m...

Future glances: More change, more tech, more harmonisation

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

Biotech

Editor's Picks